# Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use

> **NCT06489249** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Iowa** · enrollment: 24 (estimated)

## Conditions studied

- Electronic Cigarette Use
- Endothelial Dysfunction
- Inflammation

## Interventions

- **DRUG:** Placebo
- **DRUG:** Salsalate 750 MG Oral Tablet [DISALCID]

## Key facts

- **NCT ID:** NCT06489249
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2026-06
- **Final completion:** 2026-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489249, "Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT06489249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*